The adrenocortical carcinoma, a tumour of wide clinical diversity;Het bijnierschorscarcinoom, een tumor met een grote klinische verscheidenheid

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 43, 2004, Pages 2109-2113

  Schreinemakers, J M J ^a   Van Dam, P S ^b   Seldenrijk, C A ^c   Biesma, D H ^c   Rinkes, I H M Borel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADRENAL GLAND; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; GALLSTONE; HEADACHE; HEART PALPITATION; HUMAN; HYPERCORTISOLISM; HYPERTENSION; OBESITY; TUMOR DIAGNOSIS;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; LIVER NEOPLASMS; MIDDLE AGED;

EID: 7244223463     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Abecassi, M, McLoughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 1985;149:783-8.
2. Norton JA. The role of surgery in adrenal cancer. Ann Surg Oncol 1999;6:713-4.
3. Demeure MJ, Somberg LB. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies. Surg Oncol Clin N Am 1998;7:791-805.
4. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 2001;25:891-7.
5. Kopf D, Gortzki PE, Lehnert H. Clinical management of malignant adrenal tumors. J Cancer Res Clin Oncol 2001;127:143-55.
6. Favia G, Lumachi F, D'Amico DF. Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 2001;25:735-8.
7. Dackiw APB, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg 2001;25:914-26.
8. Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999;6:719-26.
9. Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C. Adrenocortical carcinoma in surgically treated patients. Surgery 1992;112:972-9.
10. Glodny B, Winde G, Herwig R, Meier A, Kuhle C, Cromme S, et al. Clinical differences between benign and malignant pheochromocytomas. Endocr J 2001;48:1511-9.
11. Kebebew E, Duh QY. Benign and malignant pheochromocytoma. Surg Oncol Clin N Am 1998;7:765-89.
12. Rossi R, Tauchmanova L, Luciano A, di Martino M, Battista C, del Viscovo L, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma. J Clin Endocrinol Metab 2000;85:1440-8.
13. Dam PS van, Gils A van, Canninga-van Dijk MR, Koning EJ de, Hofland LJ, Herder WW de. Sequential ACTH and catecholamine secretion in a phaeochromocytoma. Eur J Endocrinol 2002;147:201-6.
14. Graaf JS de, Nieweg OE, Oosterkamp AE, Zwierstra RP. Resultaten van 25 jaar feochromocytoombehandeling in het Academisch Ziekenhuis Groningen. Ned Tijdschr Geneeskd 1997;141:148-51.
15. Bonjer HJ, Bruining HA, Kazemier G, Lange JF, Pols HAP, Herder WW de. Endoscopische retroperitoneale adrenalectomie: een chirurgische aanwinst. Ned Tijdschr Geneeskd 1997;141:426-9.
16. Möbius E, Nies C, Rothmund M. Surgical treatment of pheochromocytomas: laparoscopic or conventional? Surg Endosc 1999;13:35-9.
17. Haak HR, Hermans J, Velde CJ van de, Lentjes EG, Goslings BM, Fleuren GJ, et al. Optimal treatment of adrenocortical carcinoma with mitotane. Br J Cancer 1994;69:947-51.
18. Weiss LM, Medeiros LJ, Vickery jr AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-6.
19. Hough AJ, Hollifield JW, Page DL, Hartmann WH. Prognostic factors in adrenal cortical tumors. Am J Clin Pathol 1979;72:390-9.
20. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology 1999;53:679-83.